1. Disease Overview

A ventricular septal defect (VSD) is a hole in the ventricular septum — the muscular wall that separates the heart’s two lower pumping chambers, the left and right ventricles. It is the most common congenital heart defect, present from birth in roughly one in every few hundred live births, and it also occurs in combination with many other heart malformations.

When a hole exists in this wall, oxygen-rich blood from the powerful left ventricle is pushed through the opening into the right ventricle, mixing with oxygen-poor blood. This extra blood is then re-circulated through the lungs — a pattern called a left-to-right shunt. The consequences depend almost entirely on the size of the hole and the resistance of the lung blood vessels.

Small VSDs often cause no symptoms and frequently close on their own during infancy or childhood. Large VSDs allow a large volume of blood to flood the lungs, causing breathlessness, poor feeding, failure to gain weight in babies, and — if left untreated — irreversible lung-vessel damage known as Eisenmenger syndrome. Fortunately, VSD is one of the most successfully treated heart conditions, with surgical and catheter-based closure offering excellent long-term outcomes.

2. Key Facts at a Glance

Fact	Detail
Also known as	VSD, hole in the heart, interventricular septal defect
Body system affected	Cardiovascular (heart and lungs)
Common in	Newborns and infants; most common congenital heart defect
Severity range	Tiny/harmless to large/life-threatening
Key treatments	Watchful waiting, medications, device closure, open-heart surgery
Outlook	Excellent after closure; small defects may close spontaneously

3. Alternative Names and Medical Terminology

VSD — the standard abbreviation
Hole in the heart — common lay term (though it also applies to atrial defects)
Interventricular septal defect
Perimembranous, muscular, inlet, and outlet (supracristal/conal) VSD — anatomic subtypes
Roger’s disease — a historical term for a small, restrictive VSD
Maladie de Roger — the original French eponym for a small murmur-producing defect

4. Relevant Heart, Lung or Vascular Anatomy

The heart has four chambers: two upper atria and two lower ventricles. The ventricular septum is the thick wall dividing the right ventricle (which pumps blood to the lungs) from the left ventricle (which pumps blood to the body). This septum has a large lower muscular portion and a smaller upper membranous portion, located near the aortic and tricuspid valves.

Normally, the septum is intact, keeping the two circulations separate. Because the left ventricle generates much higher pressure than the right, any opening in the septum allows blood to flow from left to right. The pulmonary arteries carrying blood to the lungs and the pulmonary vascular bed are central to how a VSD behaves, since they receive the excess shunted blood. The nearby aortic and tricuspid valves can also be affected, particularly by outlet and perimembranous defects.

5. How the Disease Affects the Body

A VSD’s effect is governed by the size of the hole and the difference in pressure between the ventricles. Through the defect, blood flows from the high-pressure left ventricle into the lower-pressure right ventricle and pulmonary arteries. This left-to-right shunt sends extra blood to the lungs and back to the left side of the heart, forcing those chambers to handle a larger-than-normal volume — a state called volume overload.

With a small (restrictive) VSD, the hole limits flow, pressures stay near normal, and the heart copes easily; often the only sign is a murmur. With a large (non-restrictive) VSD, a big volume of blood recirculates through the lungs. Over weeks to months, this causes the left atrium and left ventricle to enlarge, produces symptoms of heart failure, and raises pressure in the lung arteries (pulmonary hypertension).

If a large shunt persists for years, the lung vessels thicken and stiffen permanently. Eventually resistance in the lungs may exceed body resistance, reversing the shunt so oxygen-poor blood crosses into the body — Eisenmenger syndrome, causing blueness (cyanosis) and marking the point at which closure is no longer safe. This is why timely diagnosis and treatment of large defects matters so much.

6. Types and Classification

VSDs are classified by their location in the septum:

Perimembranous VSD — the most common type (majority of cases); located in the membranous septum near the aortic and tricuspid valves.
Muscular VSD — within the muscular septum; may be single or multiple (“Swiss-cheese” septum); many close spontaneously.
Inlet (AV canal-type) VSD — beneath the inflow (tricuspid/mitral) valves; associated with atrioventricular septal defects and Down syndrome.
Outlet VSD — also called supracristal, conal, subarterial, or doubly committed; sits below the aortic and pulmonary valves and can be associated with aortic valve leaflet prolapse.

Defects are also graded functionally by size: small/restrictive, moderate, or large/non-restrictive, based on the shunt volume and pressure relationship between the ventricles.

7. Causes of the Disease

Most VSDs are congenital, arising when the ventricular septum fails to close completely during early fetal heart development (around weeks 4–8 of pregnancy). The precise trigger is usually unknown and multifactorial, combining genetic and environmental influences.

Recognised contributors include:

Genetic and chromosomal conditions (e.g. Down syndrome, trisomy 13 and 18, and certain gene mutations)
Maternal factors during pregnancy — poorly controlled diabetes, rubella infection, alcohol, and some medications
Family history of congenital heart disease

A VSD can also be acquired later in life — most often after a heart attack (post-infarction VSD) or, rarely, following chest trauma or heart surgery.

8. How the Disease Develops

During fetal development the heart begins as a single tube that folds and divides into four chambers. The ventricular septum forms from muscular and membranous components that must fuse to seal the ventricles. When this fusion is incomplete, a defect remains.

Before birth, a VSD causes little trouble because pressures in both ventricles are similar and the lungs are not yet fully in use. After birth, lung pressures fall over the first days to weeks, creating the pressure gap that drives the left-to-right shunt. This is why many babies with a large VSD appear well at birth but develop symptoms at 4 to 8 weeks of age as pulmonary resistance drops and the shunt increases.

From there the disease follows one of several paths: small defects narrow and often close spontaneously; moderate defects may remain stable; and large defects progressively load the heart and lungs, risking heart failure and, over years, fixed pulmonary vascular disease.

9. Risk Factors

Because VSD is largely congenital, most “risk factors” relate to pregnancy and genetics rather than lifestyle:

Family history of congenital heart defects
Chromosomal conditions such as Down syndrome
Maternal diabetes (especially poorly controlled)
Maternal rubella or other infections in early pregnancy
Maternal alcohol use and certain medications during pregnancy
Premature birth (higher rate of muscular defects)

For acquired VSD, the main risk factor is a large myocardial infarction (heart attack).

10. Genetic and Family-History Factors

Most isolated VSDs are sporadic, but genetics clearly play a role. The risk of congenital heart disease is modestly higher when a parent or sibling is affected. VSDs are common features of chromosomal syndromes — particularly trisomy 21 (Down syndrome), trisomy 13, trisomy 18, and 22q11.2 deletion (DiGeorge) syndrome.

Several single-gene mutations affecting cardiac transcription factors (such as those in the NKX2-5 and GATA4 pathways) have been linked to familial VSD. Genetic counselling is recommended for families with a strong history of congenital heart disease or when a VSD is part of a wider syndrome.

11. Who Is Most at Risk?

Newborns and infants — VSD is present from birth and most often detected in early life
Babies with genetic syndromes, especially Down syndrome
Infants of mothers with diabetes, rubella, or alcohol exposure during pregnancy
Premature babies (more muscular defects, though many close)
Adults after a heart attack (acquired post-infarction VSD)
Families with a history of congenital heart disease

12. Prevalence and Epidemiology

VSD is the most common congenital heart defect, accounting for a large share of all congenital cardiac diagnoses. When small muscular defects detectable only on echocardiography are included, prevalence is even higher, as many close before they are ever recorded. It affects males and females roughly equally.

A key epidemiological feature is spontaneous closure: a substantial proportion of small and muscular VSDs close on their own during infancy and early childhood, so the prevalence in adults is much lower than at birth. VSD occurs worldwide, and its detection has risen with routine prenatal and neonatal echocardiography.

13. Signs and Symptoms

Symptoms depend heavily on defect size. Small VSDs usually cause no symptoms — the defect is often found only because a doctor hears a characteristic heart murmur.

Moderate to large VSDs, typically in infants, produce signs of excess lung blood flow and heart failure:

Fast or labored breathing, breathlessness
Poor feeding and sweating during feeds
Failure to gain weight / poor growth
Tiredness and fatigue
Frequent respiratory infections
A loud murmur, and sometimes a palpable vibration (thrill) on the chest

In older children and adults with unrepaired significant defects, symptoms may include exercise intolerance, palpitations, and breathlessness. Cyanosis (bluish skin) is not typical early but signals advanced disease (Eisenmenger physiology).

14. Early-Stage Symptoms

In the earliest stage, many infants appear entirely well, and the first clue is a murmur heard at a routine check, sometimes appearing only after the first few weeks as lung pressure falls. Early symptoms of a larger defect include faster breathing, mild sweating during feeds, and slower-than-expected weight gain. Small defects may never produce any symptoms at all.

15. Advanced-Stage Symptoms

In advanced, untreated large defects, symptoms reflect chronic heart failure and rising lung pressures: marked breathlessness, poor exercise tolerance, recurrent chest infections, and stunted growth in children. Over years, pulmonary hypertension and eventual Eisenmenger syndrome cause cyanosis (bluish lips and nail beds), clubbing of the fingers, fainting, and coughing up blood. At this stage the defect can no longer be safely closed.

16. Symptoms in Women, Men and Older Adults

VSD affects both sexes about equally and, being congenital, presents mainly in infancy regardless of gender. In adults with a previously unrecognised small VSD, the defect is often discovered incidentally through a murmur or echocardiogram. Pregnant women with a moderate-to-large shunt may notice worsening breathlessness as blood volume rises. In older adults, a long-standing shunt may present as unexplained breathlessness, arrhythmia, or pulmonary hypertension, and acquired post-infarction VSD typically causes sudden clinical deterioration after a heart attack.

17. Emergency Warning Signs

Seek emergency care for an infant or adult who has:

Severe difficulty breathing or rapid, grunting breaths
Bluish lips, tongue or skin (cyanosis)
Poor feeding with lethargy or an unresponsive baby
Sudden collapse, fainting, or chest pain (especially in an adult after a heart attack)
Coughing up blood

18. When to Seek Medical Help

Contact a doctor if a baby feeds poorly, breathes fast, sweats during feeds, or is not gaining weight, or if any murmur is heard. Adults should seek review for unexplained breathlessness, reduced exercise tolerance, palpitations, or a newly noticed murmur. Anyone with a known VSD should keep regular cardiology follow-up even when feeling well.

19. Disease Stages, Grades and Severity

VSD severity is judged mainly by shunt size and its effect on the lungs:

Small / restrictive — small hole, near-normal pressures, no or minimal symptoms; low pulmonary flow ratio.
Moderate — noticeable shunt, some heart enlargement, mild symptoms.
Large / non-restrictive — big hole, equal ventricular pressures, heart failure, and pulmonary hypertension.

Clinicians also use the pulmonary-to-systemic flow ratio (Qp:Qs) to quantify the shunt, and assess pulmonary artery pressure to gauge whether pulmonary vascular disease is developing.

20. Disease Progression

The natural course varies by type and size. Small and muscular VSDs frequently narrow and close spontaneously, often within the first two years of life. Moderate defects may remain stable or gradually cause left-heart enlargement. Large defects, if unrepaired, drive early heart failure in infancy and progressive pulmonary vascular disease over months to years, culminating in irreversible pulmonary hypertension and shunt reversal (Eisenmenger syndrome). Timely closure interrupts this progression and restores a near-normal trajectory.

21. Possible Complications

Heart failure from chronic volume overload
Pulmonary hypertension and, ultimately, Eisenmenger syndrome
Infective endocarditis (infection of the heart lining), see /disease/infective-endocarditis/
Aortic valve regurgitation (especially with outlet/perimembranous defects)
Arrhythmias (irregular heart rhythms)
Double-chambered right ventricle from muscle overgrowth
Poor growth and recurrent chest infections in infants

VSD commonly accompanies other congenital heart defects, including tetralogy of Fallot, transposition of the great arteries, atrioventricular septal defect, coarctation of the aorta, and patent ductus arteriosus. It is frequently part of genetic syndromes such as Down syndrome and 22q11.2 deletion. Associated cardiac problems include aortic regurgitation, pulmonary hypertension, heart failure, and endocarditis. In adults, an acquired VSD is linked to coronary artery disease and myocardial infarction.

23. Screening and Early Detection

Many VSDs are detected before or shortly after birth:

Prenatal ultrasound (fetal echocardiography) can identify larger defects during pregnancy, especially in high-risk pregnancies.
Newborn examination may reveal a murmur, prompting further tests.
Pulse oximetry screening of newborns helps flag more serious congenital heart disease.
Routine child health checks often first detect a murmur in an otherwise well baby.

Because small defects can be silent, some are only found incidentally later in life during examination or imaging for another reason.

24. How the Disease Is Diagnosed

Diagnosis usually begins when a doctor hears a heart murmur — the classic sign of a VSD — during a routine examination of a baby or, less often, an adult. The murmur’s character (often loud and harsh at the lower left chest) hints at the defect, and a palpable thrill may be felt.

The cornerstone diagnostic test is echocardiography (a heart ultrasound), which directly visualises the hole, shows its location, size, and number, and uses colour Doppler to demonstrate the direction and volume of the shunt. Echo also measures the effect on the heart chambers and estimates pulmonary artery pressure, guiding decisions about treatment.

Supporting tests include a chest X-ray (may show an enlarged heart and increased lung markings with a large shunt), an electrocardiogram (ECG) (may show ventricular enlargement), and sometimes cardiac MRI or CT for detailed anatomy. Cardiac catheterization is reserved for measuring pressures precisely, assessing pulmonary vascular resistance in borderline cases, or delivering device closure. Together these tests confirm the diagnosis, classify the defect, and determine whether and how it should be treated.

25. Physical Examination and Medical History

The clinician takes a history of feeding, growth, breathing, and family heart conditions, then examines the child or adult. Typical findings include a loud, harsh systolic (pan-systolic) murmur best heard at the lower left sternal border, sometimes with a palpable thrill. Large shunts may produce a fast heart rate, rapid breathing, an enlarged liver, and signs of heart failure. Interestingly, a very small VSD can produce a surprisingly loud murmur, while a very large one may be quieter.

26. Diagnostic Tests and Imaging

Echocardiography (transthoracic) — primary test; shows the defect, its type and size, shunt direction, chamber sizes, and pulmonary pressure.
Colour and spectral Doppler — quantifies the shunt and pressure gradient.
Transesophageal echocardiography (TEE) — clearer views, used during device closure or surgery.
Chest X-ray — cardiac enlargement and increased pulmonary vascularity in large shunts.
ECG — evidence of ventricular hypertrophy or strain.
Cardiac MRI/CT — detailed anatomy and accurate shunt quantification.
Cardiac catheterization — measures pressures and pulmonary vascular resistance; also therapeutic.

27. Blood Tests, Biomarkers and Genetic Testing

VSD is diagnosed by imaging, not blood tests, but labs support overall assessment. BNP or NT-proBNP may be raised when there is heart failure from a large shunt. A full blood count can show raised haemoglobin (polycythaemia) in advanced cyanotic (Eisenmenger) disease. Oxygen saturation measurement helps detect shunt reversal. Genetic testing and karyotyping are advised when a VSD occurs with features of a syndrome (e.g. Down syndrome or 22q11.2 deletion), and genetic counselling may be offered to families.

28. Understanding Test Results

Key results to understand include the defect size and location on echo, the Qp:Qs ratio (how much extra blood flows to the lungs — a ratio well above normal indicates a significant shunt), and the pulmonary artery pressure. Normal or mildly raised pressures with a small shunt suggest a defect that can be safely watched. A large shunt with enlarged left-heart chambers points toward closure. High, fixed pulmonary pressures signal advanced pulmonary vascular disease, which may make closure unsafe. Your cardiologist will interpret these together in the context of symptoms and growth.

29. Differential Diagnosis

Other conditions that can produce similar murmurs or symptoms include atrial septal defect (ASD), atrioventricular septal defect, patent ductus arteriosus, pulmonary or aortic valve stenosis, mitral regurgitation, tetralogy of Fallot, and an innocent (harmless) childhood murmur. Echocardiography reliably distinguishes a VSD from these, which is why it is central to diagnosis. In adults presenting after a heart attack, acquired post-infarction VSD must be separated from acute mitral regurgitation and free-wall rupture.

30. Specialist and Multidisciplinary Evaluation

Care is led by a paediatric or adult congenital cardiologist, working with a congenital cardiac surgeon, interventional cardiologist, cardiac anaesthetist, specialist nurses, and, where relevant, a geneticist and neonatologist. Feeding specialists and dietitians support infants with poor growth. This multidisciplinary team reviews the anatomy, symptoms, and test results together to recommend watchful waiting, device closure, or surgery, and to plan lifelong follow-up. Explore experienced doctors and specialist hospitals for congenital heart care.

31. Treatment Goals

Prevent or reverse heart failure from volume overload
Protect the lungs by preventing pulmonary vascular disease before it becomes irreversible
Restore normal growth and development in children
Eliminate the shunt where the defect is significant
Reduce the risk of endocarditis and arrhythmia
Preserve long-term heart function and quality of life

32. When Is Treatment Required?

Not every VSD needs intervention. Small defects with no symptoms and normal heart size are usually watched, as many close on their own. Closure is recommended when there is a significant left-to-right shunt causing heart enlargement, symptoms, or failure to thrive; when there is pulmonary hypertension that remains reversible; when the defect causes aortic valve prolapse or regurgitation; or after an episode of endocarditis. The timing balances the chance of spontaneous closure against the risk of lung damage.

33. Active Monitoring and Watchful Waiting

For small, asymptomatic VSDs, watchful waiting is standard because of the high rate of spontaneous closure. This involves regular reviews with a cardiologist, periodic echocardiograms to check the defect and heart size, and monitoring of growth and symptoms in children. Families are reassured that the child can usually live normally during this period. Medications and heart-failure treatment are added only if symptoms appear, and referral for closure is made if the defect enlarges its effect rather than shrinking.

34. Medications

Medications do not close a VSD but manage symptoms and heart failure while awaiting spontaneous closure or surgery:

Diuretics (e.g. furosemide) — reduce fluid overload and ease breathing
ACE inhibitors — lower afterload and reduce shunt burden
Digoxin — sometimes used to support heart function
Nutritional support / high-calorie feeds — help infants grow
Pulmonary vasodilators — reserved for advanced pulmonary hypertension/Eisenmenger physiology
Endocarditis prevention — good dental hygiene; antibiotics per current guidelines in selected cases

35. Minimally Invasive Treatments

For suitable defects, minimally invasive and hybrid approaches avoid a full open-heart operation. Transcatheter device closure delivers a closure device through a vein in the leg to plug the defect without opening the chest — well suited to many muscular and selected perimembranous VSDs. Hybrid procedures combine a small surgical incision with catheter techniques, useful in small infants or difficult muscular defects. Minimally invasive surgery through smaller incisions is offered at some specialist centres. These options often mean shorter hospital stays and faster recovery.

36. Catheter-Based and Endovascular Treatments

Transcatheter (percutaneous) device closure is a key advance. Under imaging guidance, a catheter is threaded from a leg vein to the heart, and a specially designed occluder device is deployed across the defect, where it seals the hole and is later covered by the heart’s own lining. It is most established for muscular VSDs and increasingly used for selected perimembranous defects with appropriate anatomy. Advantages include no sternotomy, no bypass, and rapid recovery. Careful case selection avoids devices near the conduction system or aortic valve. See related procedures.

37. Surgical Treatment Options

Open surgical closure remains the gold standard for large or complex VSDs and for defects unsuitable for a device. The operation is performed under general anaesthesia using a heart-lung (cardiopulmonary bypass) machine, usually through a midline chest incision (sternotomy). The surgeon reaches the defect — most often through the right atrium and tricuspid valve — and closes it with a synthetic (Dacron/PTFE) or pericardial patch, or with direct sutures for small muscular holes. The patch becomes covered by the heart’s own tissue over time, permanently sealing the shunt.

Surgery is highly successful, with low mortality in experienced centres and excellent long-term results. Most children undergo repair in infancy or early childhood, timed to prevent lung damage while allowing small defects a chance to close first. Complex cases — multiple muscular defects, associated lesions, or “Swiss-cheese” septa — may need tailored techniques or staged procedures, sometimes including temporary pulmonary artery banding in tiny or high-risk infants to protect the lungs until definitive repair. Acquired post-infarction VSD requires urgent, specialised surgical repair. Explore surgery and congenital heart procedures options.

38. Advanced and Emerging Treatments

Innovation continues to refine VSD care. Newer occluder devices with softer, more flexible designs reduce the risk of injuring the conduction system, expanding catheter closure to more perimembranous defects. 3D echocardiography, cardiac MRI, and 3D-printed heart models improve planning of complex repairs. Robotic and minimally invasive surgical techniques are being adopted at leading centres. Research into bioabsorbable devices and improved patch materials aims to leave less permanent hardware in the growing heart. Care for adults with congenital heart disease is a rapidly growing specialty in its own right.

39. Treatment Options Compared

Watchful waiting — best for small, symptom-free defects; no procedure, but requires ongoing monitoring.
Medications — control symptoms and heart failure; do not close the hole.
Device (catheter) closure — no open surgery, quick recovery; suited to muscular and selected perimembranous defects.
Open surgical closure — most versatile and definitive; needed for large, inlet, outlet, or complex defects; longer recovery.
Hybrid/pulmonary artery banding — temporising or specialised approaches for very small infants or difficult anatomy.

The right choice depends on defect size, location, patient age and size, and associated problems.

40. How Doctors Choose the Right Treatment

Doctors weigh the size and location of the defect, the shunt volume (Qp:Qs), pulmonary artery pressure, the patient’s age, weight and symptoms, and any associated lesions or valve involvement. A small, shrinking defect favours observation; a large, symptomatic one favours prompt closure. Muscular defects and good anatomy favour a device; inlet, outlet, or defects near the aortic valve usually favour surgery. Reversible pulmonary hypertension supports closure, whereas fixed, severe pulmonary vascular disease may contraindicate it. Decisions are made jointly by the multidisciplinary team with the family.

41. Benefits and Risks of Treatment

Benefits: closing a significant VSD relieves symptoms, restores growth, protects the lungs, prevents heart failure, and lowers endocarditis risk, with most patients achieving a near-normal life expectancy.

Risks: as with any heart procedure, there are small risks of bleeding, infection, arrhythmia (including heart block that occasionally needs a pacemaker), residual shunt, and, with devices, device migration or valve interference. In experienced centres these risks are low and are outweighed by the benefits when closure is indicated.

42. What Happens If the Disease Is Left Untreated?

The outcome of an untreated VSD depends on size. Small defects often cause no long-term harm and may close by themselves. Large defects left untreated lead to progressive heart failure in infancy, poor growth, recurrent chest infections, and — most seriously — irreversible pulmonary vascular disease. Over years, rising lung pressure reverses the shunt, producing Eisenmenger syndrome with cyanosis, reduced life expectancy, and a defect that can no longer be safely closed. Untreated defects also carry a lifelong risk of infective endocarditis.

43. Treatment Success and Expected Outcomes

VSD closure is among the most successful of all heart operations. When repair is done at the right time, most patients — especially children — recover fully and go on to live normal, active lives with normal life expectancy. Residual shunts are usually small and often close over time. Long-term studies show excellent survival and quality of life after timely closure. Outcomes are best when the defect is treated before irreversible pulmonary hypertension develops, underscoring the value of appropriate timing and expert care.

44. Prognosis and Long-Term Outlook

The long-term outlook for VSD is generally excellent, particularly for small defects and for larger defects closed in a timely manner. Many small and muscular VSDs close spontaneously in childhood and never cause problems. After successful closure, most patients have normal heart function, normal exercise capacity, and a normal life expectancy, and most restrictions are lifted.

The prognosis is less favourable only when treatment is delayed until irreversible pulmonary vascular disease (Eisenmenger syndrome) has developed, which limits both treatment options and survival. A minority of patients need long-term follow-up for issues such as a small residual shunt, aortic valve regurgitation, arrhythmias, or conduction problems after surgery. Overall, with modern paediatric and adult congenital cardiac care, the vast majority of people with a VSD do very well, and lifelong cardiology review ensures any late issues are caught early.

45. Recovery and Rehabilitation

After device closure, recovery is quick — often a hospital stay of a day or two and return to normal activity within about a week, with short-term antiplatelet medication and avoidance of strenuous activity while the device endothelialises. After open surgery, infants and children typically stay in hospital for several days to a week and recover fully over a few weeks, with wound care and gradual return to activity. Cardiac rehabilitation and follow-up echocardiograms confirm the defect is closed. Most patients, especially children, bounce back remarkably well.

46. Follow-Up Tests and Long-Term Monitoring

Follow-up after treatment includes periodic clinical review and echocardiography to confirm the defect stays closed, assess heart function, and check the aortic valve and pulmonary pressures. ECGs monitor for arrhythmia or conduction issues after surgery. Patients with small unrepaired defects need occasional review to confirm stability. Adults with repaired VSD should maintain lifelong congenital-cardiology follow-up, even when symptom-free, as occasional late issues can be managed effectively if detected early.

47. Managing Recurrence or Disease Progression

True recurrence of a properly closed VSD is uncommon. When issues arise, they usually involve a small residual shunt, a new or worsening aortic valve leak, arrhythmia, or late pulmonary hypertension. Management is tailored: small residual shunts are often simply monitored; significant ones may need repeat closure; valve or rhythm problems are treated on their own merits. Ongoing surveillance allows progression to be caught and addressed early, keeping most patients stable long-term.

48. Living with the Disease

Most people with a small or repaired VSD live completely normal lives with no restrictions. Children can attend school, play, and take part in sports. Good dental hygiene helps prevent endocarditis, and patients should tell healthcare providers about their heart history before procedures. Adults with repaired defects can usually work, exercise, and travel freely. Those with unrepaired significant defects or pulmonary hypertension need more careful lifestyle planning guided by their cardiologist. Living with a VSD is, for the great majority, entirely manageable.

49. Diet and Nutrition Guidelines

For infants with a large VSD and heart failure, nutrition is a priority: high-calorie feeds, smaller frequent feeds, and sometimes tube feeding help babies grow while awaiting closure. A dietitian may guide fortification of feeds. For older children and adults, a balanced, heart-healthy diet rich in fruits, vegetables, whole grains and lean protein, with limited salt if there is heart failure, supports overall cardiovascular health. Adequate iron intake matters in cyanotic patients. There is no special “VSD diet” once the defect is closed and the heart is normal.

50. Exercise and Physical-Activity Guidelines

After successful closure with normal heart function, most patients have no exercise restrictions and are encouraged to be active. Children with small defects can usually play and take part in sports normally. Those with a large unrepaired defect, pulmonary hypertension, or Eisenmenger syndrome need individualised advice and should avoid intense or competitive exertion. Always confirm activity levels with your cardiologist, especially before competitive sport or heavy physical work, and after any recent procedure.

51. Medications, Activities and Habits to Avoid

Avoid dehydration and extreme exertion if you have significant pulmonary hypertension.
Do not skip cardiology follow-up, even when feeling well.
Maintain excellent dental hygiene and follow endocarditis-prevention advice; avoid untreated dental infections.
Avoid smoking and second-hand smoke, which harm the lungs and heart.
Pregnancy should be planned with specialist input if you have a significant defect or pulmonary hypertension.
Discuss all new medications with your cardiologist, particularly if on antiplatelet therapy after a device.

52. Preventing the Disease or Reducing Its Risks

Most VSDs cannot be prevented because their cause is unknown. However, risks can be reduced by good prenatal care: controlling maternal diabetes, being vaccinated against rubella before pregnancy, avoiding alcohol and unnecessary medications in pregnancy, taking folic acid, and avoiding smoking. Genetic counselling helps families with a history of congenital heart disease. For the acquired form, preventing heart attacks through cardiovascular risk management lowers the chance of a post-infarction VSD.

53. Pregnancy and the Disease

Women with a small or repaired VSD and normal heart function usually tolerate pregnancy well, though pre-pregnancy cardiology review is wise. A significant unrepaired shunt can worsen with the extra blood volume of pregnancy and needs specialist monitoring. Pulmonary hypertension / Eisenmenger syndrome carries high maternal risk, and pregnancy is generally strongly discouraged in these cases. Because VSD has a genetic component, fetal echocardiography may be offered. Care should be shared between an obstetrician and a congenital-heart specialist.

54. Disease in Children and Young Adults

VSD is fundamentally a condition of infancy and childhood. Many small defects close spontaneously in the first years of life, while large defects are typically repaired in infancy to protect the lungs and support growth. Children who undergo closure usually grow and develop normally afterward. Young adults may present with a previously unrecognised small defect found on examination, or attend adult congenital heart clinics for lifelong follow-up after childhood repair. Transition from paediatric to adult congenital care is an important step.

55. Disease in Older Adults

Isolated VSD is less common in older adults because most significant defects are treated or close in childhood. When seen, it may be a small lifelong defect discovered incidentally, a repaired defect under long-term surveillance, or an acquired post-infarction VSD after a heart attack — the latter a serious emergency. Older adults with long-standing shunts may have developed pulmonary hypertension or arrhythmias requiring specialist management. Age-related conditions such as coronary artery disease may coexist and influence care.

56. Emotional Health and Patient Support

A diagnosis of a heart defect in a baby is understandably frightening for families, and adults facing a procedure may feel anxious. Reassurance that VSD is highly treatable with excellent outcomes helps enormously. Support comes from the cardiac team, patient organisations, and congenital-heart-disease support groups for parents and adult patients. Counselling, peer support, and clear information reduce anxiety. Caregivers should also look after their own wellbeing. Read real experiences from patients and families in our patient stories.

57. Preparing for Your Specialist Appointment

Bring a list of symptoms, feeding and growth records for a child, and any prior test results or echo reports.
Note the defect’s size, type and location if already known.
List current medications and allergies.
Write down questions you want answered (see next section).
Bring family history of congenital heart disease.
Consider bringing a partner or relative for support and to help remember information.

58. Questions to Ask Your Doctor

What type and size of VSD does my child or I have?
Is it likely to close on its own, and if so, by when?
Does it need treatment, and if so, when and which type?
What are the risks and benefits of device closure versus surgery?
Will it affect growth, development, or exercise?
What are the signs of worsening I should watch for?
What is the long-term outlook after treatment?
Do we need endocarditis prevention or dental precautions?
How often will we need follow-up and echocardiograms?
Are there implications for pregnancy or family planning?

59. Cost of Diagnosis and Treatment

Costs vary widely by country, hospital, and complexity. The figures below are approximate ranges for VSD closure and highlight the medical-tourism advantage.

Region	Approx. cost of VSD closure (surgery/device)
United States	~$40,000 – $150,000+
United Kingdom (private)	~£15,000 – £40,000
India	~$4,000 – $9,000
Turkey	~$6,000 – $14,000
Thailand	~$8,000 – $18,000
Singapore	~$15,000 – $35,000

Destinations such as India, Turkey and Thailand often cost 50–90% less than the US or UK for comparable quality at accredited centres. Explore destinations for details.

60. Factors Affecting Treatment Cost

Type of procedure — device closure vs open surgery vs hybrid
Defect complexity — single vs multiple or associated lesions
Patient age and weight (neonatal/infant care costs more)
Hospital accreditation, reputation, and location
Length of ICU and hospital stay
Device and implant costs
Pre-operative tests, anaesthesia, and surgeon fees
Post-operative care, medications, and follow-up
Travel, accommodation, and interpreter needs for medical tourists

61. Choosing the Right Specialist

Look for a paediatric or adult congenital cardiologist and, for closure, a congenital cardiac surgeon or interventional cardiologist with specific experience in VSD. Consider their case volume, outcomes, board certification, and subspecialty training, and whether they work within a dedicated congenital-heart team. For device closure, choose an interventionalist experienced with VSD occluders. Do not hesitate to ask about experience and results. Browse qualified doctors on our portal.

62. Choosing the Right Hospital or Treatment Centre

Choose a centre with a dedicated congenital / paediatric cardiac programme, a specialised cardiac ICU, and strong outcome data. International accreditation (such as JCI) signals quality and safety standards, important for medical tourists. High procedure volume generally correlates with better results. Check the availability of both surgical and catheter-based options, multidisciplinary support, and clear follow-up arrangements. Explore leading hospitals and destinations for congenital heart surgery.

63. Getting a Second Medical Opinion

A second opinion is worthwhile before any heart procedure, especially for borderline decisions about whether and when to close a VSD, or which technique to use. Another specialist can confirm the diagnosis, review the echo, and discuss alternatives, giving families confidence. Reputable centres welcome second opinions. Gather your reports and imaging to share. You can request a second opinion through our portal.

64. Treatment Abroad and Medical-Travel Considerations

Many families travel abroad for VSD treatment to access high-quality, accredited care at lower cost, often with shorter waiting times. Popular destinations include India, Turkey, Thailand, and Singapore, where JCI-accredited hospitals offer experienced congenital cardiac teams. When planning treatment abroad, consider surgeon and hospital credentials, the total package cost, travel and recovery time, language support, and arrangements for follow-up once home. Coordinate closely with your local cardiologist for continuity of care. See our destinations guide.

65. Frequently Asked Questions

Will my baby’s VSD close on its own? Many small and muscular VSDs close spontaneously during infancy and early childhood. Your cardiologist will monitor with echocardiograms and advise.

Is VSD dangerous? Small defects are usually harmless. Large defects can cause heart failure and lung damage if untreated, but are very treatable when addressed in time.

Does every VSD need surgery? No. Small, symptom-free defects are often just watched. Only significant defects require closure by device or surgery.

What is the difference between device closure and surgery? Device closure uses a catheter through a leg vein with no open-heart operation; surgery uses a patch under bypass and suits large or complex defects.

Can my child live a normal life after treatment? Yes. Most children lead completely normal, active lives with normal life expectancy after successful closure.

Is VSD inherited? Most cases are sporadic, but risk is modestly higher with a family history or certain genetic syndromes.

What is Eisenmenger syndrome? It is irreversible lung-vessel damage from a long-standing large shunt, causing shunt reversal and cyanosis — the reason large defects should be treated early.

Do we need antibiotics before dental work? Endocarditis-prevention advice depends on individual risk and current guidelines; ask your cardiologist and keep good dental hygiene.

66. Patient Stories and Treatment Experiences

The following are representative, anonymised examples for illustration.

Meera, India — Meera’s daughter was diagnosed with a large perimembranous VSD at six weeks after poor feeding and fast breathing. She had surgical patch closure at eight months and is now a thriving, active toddler with a normal heart.
James, United Kingdom — James, 29, learned of a small VSD when a murmur was found during a routine check. His cardiologist advised watchful waiting; annual echoes have shown it remains small and symptom-free, and he lives an entirely normal life.
Amara, Nigeria — Amara travelled abroad with her son for transcatheter device closure of a muscular VSD at a JCI-accredited centre. He was home within days and returned to normal activity within a week.

67. Latest Research and Clinical Trials

Research continues to improve VSD care. Advances include softer, safer occluder devices that reduce the risk of heart block, expanding catheter closure to more perimembranous defects; bioabsorbable device materials; and refined minimally invasive and hybrid techniques. Imaging progress with 3D echo, cardiac MRI, and 3D-printed models improves planning of complex repairs. Growth of adult congenital heart disease research is enhancing lifelong care. Major guideline bodies periodically update recommendations. Ask your specialist whether any registries or trials are relevant to your situation.

70. Medical Glossary

Ventricular septum — the wall dividing the heart’s two lower chambers.
Shunt — abnormal blood flow between chambers through a defect.
Left-to-right shunt — flow from the higher-pressure left side to the right side.
Restrictive VSD — a small defect that limits flow and keeps pressures near normal.
Perimembranous VSD — the most common type, near the aortic and tricuspid valves.
Muscular VSD — a defect within the muscular part of the septum.
Qp:Qs — ratio of lung to body blood flow, measuring shunt size.
Pulmonary hypertension — high blood pressure in the lung arteries.
Eisenmenger syndrome — irreversible lung-vessel disease with shunt reversal and cyanosis.
Cyanosis — bluish skin from low blood oxygen.
Occluder device — an implant used to plug the defect via catheter.
Cardiopulmonary bypass — heart-lung machine used during open surgery.
Pulmonary artery banding — a procedure to protect the lungs by limiting blood flow.
Endocarditis — infection of the heart’s inner lining.

71. Medical Review, Editorial Policy and Last Updated Date

Last updated: 11 July 2026. This article is written for patient education and reviewed by qualified cardiac specialists in line with our editorial policy. Content is based on established cardiology sources and guidelines (including ACC/AHA, ESC, and NHS resources) and is reviewed periodically for accuracy. It uses general, approximate information and avoids invented statistics.

Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation.

72. Clinical Guidelines and Medical References

General guidance for VSD is provided by recognised bodies, including:

American College of Cardiology / American Heart Association (ACC/AHA) — congenital and adult congenital heart disease guidelines
European Society of Cardiology (ESC) — guidelines for adult congenital heart disease
National Health Service (NHS, UK) — patient information on congenital heart defects
World Health Organization (WHO) — congenital anomalies resources
Standard cardiology and paediatric cardiology textbooks

These sources are referenced generally; consult your specialist for guidance specific to your case.

73. Book an Appointment or Request a Second Opinion

If you or your child has a ventricular septal defect, expert help is available. Our specialists can review your diagnosis, explain your options, and guide you to the right treatment at accredited hospitals worldwide.

Book an appointment: /contact/
Request a second opinion or ask a question: /contact/
Explore hospitals, doctors, and destinations for congenital heart care.

Ventricular Septal Defects